Logo image of ACCS

ACCESS NEWSWIRE INC (ACCS) Stock Fundamental Analysis

NYSEARCA:ACCS - NYSE Arca - US46520M2044 - Common Stock - Currency: USD

9.67  -1.05 (-9.81%)

Fundamental Rating

3

Taking everything into account, ACCS scores 3 out of 10 in our fundamental rating. ACCS was compared to 284 industry peers in the Software industry. While ACCS is still in line with the averages on profitability rating, there are concerns on its financial health. ACCS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year ACCS was profitable.
In the past year ACCS had a positive cash flow from operations.
Each year in the past 5 years ACCS has been profitable.
In the past 5 years ACCS always reported a positive cash flow from operatings.
ACCS Yearly Net Income VS EBIT VS OCF VS FCFACCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.15%, ACCS is in line with its industry, outperforming 55.80% of the companies in the same industry.
ACCS's Return On Equity of -3.75% is in line compared to the rest of the industry. ACCS outperforms 57.97% of its industry peers.
ACCS has a better Return On Invested Capital (0.41%) than 63.41% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACCS is significantly below the industry average of 11.91%.
The 3 year average ROIC (4.56%) for ACCS is well above the current ROIC(0.41%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.15%
ROE -3.75%
ROIC 0.41%
ROA(3y)4.16%
ROA(5y)4.13%
ROE(3y)6.13%
ROE(5y)5.7%
ROIC(3y)4.56%
ROIC(5y)4.12%
ACCS Yearly ROA, ROE, ROICACCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10

1.3 Margins

ACCS's Profit Margin has declined in the last couple of years.
The Operating Margin of ACCS (1.14%) is better than 64.13% of its industry peers.
In the last couple of years the Operating Margin of ACCS has remained more or less at the same level.
The Gross Margin of ACCS (75.11%) is better than 67.03% of its industry peers.
ACCS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.14%
PM (TTM) N/A
GM 75.11%
OM growth 3Y-16.6%
OM growth 5Y0.64%
PM growth 3Y-41.34%
PM growth 5Y-17.16%
GM growth 3Y2.51%
GM growth 5Y1.39%
ACCS Yearly Profit, Operating, Gross MarginsACCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACCS is destroying value.
Compared to 1 year ago, ACCS has more shares outstanding
The number of shares outstanding for ACCS has been reduced compared to 5 years ago.
The debt/assets ratio for ACCS has been reduced compared to a year ago.
ACCS Yearly Shares OutstandingACCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
ACCS Yearly Total Debt VS Total AssetsACCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

ACCS has an Altman-Z score of 1.63. This is a bad value and indicates that ACCS is not financially healthy and even has some risk of bankruptcy.
ACCS has a Altman-Z score (1.63) which is in line with its industry peers.
The Debt to FCF ratio of ACCS is 7.06, which is on the high side as it means it would take ACCS, 7.06 years of fcf income to pay off all of its debts.
ACCS has a Debt to FCF ratio (7.06) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.47 indicates that ACCS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.47, ACCS is doing worse than 67.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 7.06
Altman-Z 1.63
ROIC/WACC0.03
WACC11.84%
ACCS Yearly LT Debt VS Equity VS FCFACCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.3 Liquidity

ACCS has a Current Ratio of 0.80. This is a bad value and indicates that ACCS is not financially healthy enough and could expect problems in meeting its short term obligations.
ACCS has a Current ratio of 0.80. This is amonst the worse of the industry: ACCS underperforms 83.70% of its industry peers.
ACCS has a Quick Ratio of 0.80. This is a bad value and indicates that ACCS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.80, ACCS is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.8
Quick Ratio 0.8
ACCS Yearly Current Assets VS Current LiabilitesACCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

ACCS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.67%.
ACCS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.51% yearly.
The Revenue for ACCS has decreased by -11.64% in the past year. This is quite bad
ACCS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.59% yearly.
EPS 1Y (TTM)-52.67%
EPS 3Y10.84%
EPS 5Y-3.51%
EPS Q2Q%-37.04%
Revenue 1Y (TTM)-11.64%
Revenue growth 3Y21.68%
Revenue growth 5Y18.59%
Sales Q2Q%-8.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-43.42%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACCS Yearly Revenue VS EstimatesACCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACCS Yearly EPS VS EstimatesACCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.60, the valuation of ACCS can be described as correct.
85.51% of the companies in the same industry are more expensive than ACCS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ACCS to the average of the S&P500 Index (30.43), we can say ACCS is valued slightly cheaper.
With a Price/Forward Earnings ratio of 13.35, ACCS is valued correctly.
ACCS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ACCS is cheaper than 89.13% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ACCS to the average of the S&P500 Index (23.78), we can say ACCS is valued slightly cheaper.
Industry RankSector Rank
PE 15.6
Fwd PE 13.35
ACCS Price Earnings VS Forward Price EarningsACCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACCS is valued cheaply inside the industry as 89.49% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACCS indicates a rather cheap valuation: ACCS is cheaper than 88.77% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.76
EV/EBITDA 14.73
ACCS Per share dataACCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACCS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACCESS NEWSWIRE INC

NYSEARCA:ACCS (2/18/2025, 6:40:03 PM)

9.67

-1.05 (-9.81%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)03-06 2025-03-06/amc
Inst Owners41.62%
Inst Owner ChangeN/A
Ins Owners19.4%
Ins Owner ChangeN/A
Market Cap37.04M
Analysts82.86
Price TargetN/A
Short Float %0.15%
Short Ratio0.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.98%
Min EPS beat(2)-16.67%
Max EPS beat(2)2.71%
EPS beat(4)1
Avg EPS beat(4)-32.59%
Min EPS beat(4)-72.95%
Max EPS beat(4)2.71%
EPS beat(8)3
Avg EPS beat(8)-20.72%
EPS beat(12)5
Avg EPS beat(12)-9.15%
EPS beat(16)7
Avg EPS beat(16)-0.32%
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.53%
Max Revenue beat(2)-1.08%
Revenue beat(4)0
Avg Revenue beat(4)-9.03%
Min Revenue beat(4)-20.63%
Max Revenue beat(4)-1.08%
Revenue beat(8)1
Avg Revenue beat(8)-7.46%
Revenue beat(12)2
Avg Revenue beat(12)-6.46%
Revenue beat(16)5
Avg Revenue beat(16)-3.37%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.6
Fwd PE 13.35
P/S 1.27
P/FCF 15.76
P/OCF 12.09
P/B 1.05
P/tB N/A
EV/EBITDA 14.73
EPS(TTM)0.62
EY6.41%
EPS(NY)0.72
Fwd EY7.49%
FCF(TTM)0.61
FCFY6.35%
OCF(TTM)0.8
OCFY8.27%
SpS7.61
BVpS9.21
TBVpS-3.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.15%
ROE -3.75%
ROCE 0.68%
ROIC 0.41%
ROICexc 0.45%
ROICexgc N/A
OM 1.14%
PM (TTM) N/A
GM 75.11%
FCFM 8.06%
ROA(3y)4.16%
ROA(5y)4.13%
ROE(3y)6.13%
ROE(5y)5.7%
ROIC(3y)4.56%
ROIC(5y)4.12%
ROICexc(3y)10.86%
ROICexc(5y)10.28%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.05%
ROCE(5y)6.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-39.51%
ROICexc growth 5Y-14.74%
OM growth 3Y-16.6%
OM growth 5Y0.64%
PM growth 3Y-41.34%
PM growth 5Y-17.16%
GM growth 3Y2.51%
GM growth 5Y1.39%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 7.06
Debt/EBITDA 4.9
Cap/Depr 23.36%
Cap/Sales 2.45%
Interest Coverage 0.26
Cash Conversion 90.41%
Profit Quality N/A
Current Ratio 0.8
Quick Ratio 0.8
Altman-Z 1.63
F-Score3
WACC11.84%
ROIC/WACC0.03
Cap/Depr(3y)15.88%
Cap/Depr(5y)15.21%
Cap/Sales(3y)1.02%
Cap/Sales(5y)1.18%
Profit Quality(3y)224.52%
Profit Quality(5y)246.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-52.67%
EPS 3Y10.84%
EPS 5Y-3.51%
EPS Q2Q%-37.04%
EPS Next Y-43.42%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.64%
Revenue growth 3Y21.68%
Revenue growth 5Y18.59%
Sales Q2Q%-8.14%
Revenue Next Year-14.87%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-88.77%
EBIT growth 3Y1.49%
EBIT growth 5Y19.35%
EBIT Next Year58.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-46.25%
FCF growth 3Y-16.29%
FCF growth 5Y-1.78%
OCF growth 1Y-30.94%
OCF growth 3Y-11.31%
OCF growth 5Y1.3%